Mary Lou Biggs, project director and epidemiologist at the Collaborative Health Studies Coordinating Center (CHSCC) in the Department of Biostatics, is co-author of this study that found that a single fasting serum NEFA concentration was not independently associated with long-term adverse kidney outcomes in a cohort of older community-living adults.
